cj#666> CODEX and drugs


Richard Moore

Dear cj,

Codex is interesting as an example of how our coming world government is
planning to operate.  With little or no publicity, a remote, corporate-run
commission is quietly deciding the rules which will directly effect all of
our lives.

The whole thing is a stealth operation - at the micro level (these codex
regulations) and at the macro level (the installation of a corporate world
government).  National sovereignty and democracy are being lost - certainly
not with a bang, and with scarce few whimpers.

Is there anyone from Norway or Germany who can cofirm the status of vitamin
availability in those countries currently?


BTW> Note irony re #666 ... the codex of the beast?

Date: Thu, 24 Apr 1997
To: "Richard K. Moore" <•••@••.•••>
From: Andrew Curry <•••@••.•••>
Subject: "Special" McLuhan Post -- NOT ARCHIVED


This may be of interest, if you don't see the McLuhan list anyway.

Andrew Curry.

  ------- Forwarded message follows -------

Dear McLuhan Post subscriber,

This is a special post, not archived.

The topic -- a familiar one to older subscribers
-- is the UN "Codex" about to be implementend to
BAN VITAMINS in the US, Canada, and other member

The text (below) is taken from the FDA's own
website. If you read through the doubletalk, you
will find that "harmonizing" with the Codex means
simply banning vitamins unless prescribed by a
doctor at a cost of maybe 10-20X what vitamins
cost now, which is already high. This means that
in your ripe old age, dear reader, all that you
will be able to rely on for health protection is
fresh veggies and the prescription
drugs/supplements sparingly issued by the world
drug cartels.

We are sending this as a Special Post because many
of our readers continue to (want to) believe we
are crying "wolf" and making this up. We are not.

At the end of the message is the address of the
only organization in NA totally dedicated to
STOPPING THE CODEX. Call or write them . This is
YOUR HEALTH on the line.

[Instructions on de-listing from this McLuhan List
accompany the regular monthly posts, plus are on
our site at www.mediaguru.org. Delist instructions
sent to our editorial URL, above, will
unfortunately be ignored.]

-------------------- as received -----

FROM FDA SITE AT http://www.fda.gov/ola/319.htm

The regulatory framework administered by the Food and Drug
Administration (FDA) to provide public health and safety
protection to American consumers is a model that many countries strive
to emulate. At the same time, FDA recognizes that we
operate in an increasingly more global, more interdependent market
environment, and that American consumers can realize
significant public health and economic benefits from efforts by FDA to
share information, explore opportunities to collaborate
on assessments and product reviews, and harmonize standards with its
foreign counterparts. Growing demands on FDA's
resources to assure the safety and efficacy of greater numbers of
increasingly more complex products produced both here and
abroad, absolutely mandate that FDA seek ways in which it can share its
regulatory workload while maintaining public health
protection for American consumers. Science driven harmonization can
curtail duplication and thereby significantly reduce the
cost of new drug development, in terms of the risks to which patients
are exposed, the experimentation with animals, the
regulatory costs to government and the cost to industry.

For many years, FDA has actively engaged in the kinds of information
exchange that lay the foundation for the development
and maintenance of high international standards, and pave the way for
harmonization activities. We have entered into numerous
Memoranda of Understanding (MOU) with other governments to ensure that
their products intended for export to the United
States adhere to our strict standards of health and safety protection.
We also participate in limited and focused education and
training initiatives that instruct others in how to conduct their
activities so that products shipped to the U.S. will be in accord
with U.S. requirements. We exert leadership in a number of international
standard-setting organizations.

FDA has been a strong supporter of, and participant in, the Codex
Alimentarius Commission (Codex). Codex is an
international standards-setting organization for food safety composed of
national governments from more than 150 countries.
The work of Codex is increasingly important with the recognition of
Codex as the relevant international standards-setting body
for food safety in the Agreement on the Application of Sanitary and
Phytosanitary Measures (SPS) resulting from the Uruguay
Round of multilateral trade negotiations.

Since its inception, Codex has developed in excess of 200 Commodity
Standards, more than 40 codes and guidelines, about
2,500 pesticide/commodity maximum limits, and has reviewed the safety of
over 500 food additives and contaminants. FDA,
through its participation on most Codex Committees, provides scientific
and regulatory expertise and forcefully presents U.S.
views at the committee meetings.

FDA plans to amend its regulations and procedures for consideration of
standards adopted by Codex. This action is being
taken to provide for the systematic review of the Codex Standards in
order to enhance consumer protection, promote
international harmonization and fulfill obligations of the United States
under international agreements.

In recent years, we have put considerable effort into the work of the
International Conference on Harmonization (ICH),
working closely with our regulatory counterparts in Japan and the
European Union, as well as the three areas' organizations
representing the major research and development pharmaceutical companies
(e.g., the Pharmaceutical Research and
Manufacturer's Association (PhRMA)). The goal of ICH is to harmonize
across all three regions the requirements for data
submitted to support safety, efficacy and quality determinations in new
drug applications, and to develop guidelines for the
industry based on the harmonized requirements. The past six years of
effort have produced over 40 new harmonized
guidelines, and another 20 are in various stages of development and
review. The ICH effort is one of the best examples of a
forward-thinking Agency that is willing to work not only with its
regulatory counterparts, but with the regulated industry as well,
to develop guidelines harmonized to the highest standards while also
eliminating costly duplication of effort. Similar efforts are
underway in the areas of medical devices and veterinary drugs.

Additionally, for the past three years we have been involved in
negotiations to give limited recognition to inspections of drug
and device facilities by European Union authorities and to expand the
third party device review to include European Union
notified bodies. A successful agreement has the potential to save
resources for both sides, however, FDA must be satisfied
that such an agreement would not compromise our responsibility for
protecting American consumers.

International Advocates for Health Freedom
John C. Hammell, Legislative Advocate
2411 Monroe St.#2 Hollywood, FL 33020 USA
800-333-2553, 954-929-2905, FAX 954-929-0507,
FAX ON DEMAND 954-927-8795,•••@••.•••
til have own website: http://www.lef.org


Posted by Richard K. Moore - •••@••.••• - PO Box 26   Wexford, Ireland
  Cyberlib:  ftp://ftp.iol.ie/users/rkmoore/cyberlib    |   (USA Citizen)
  * Non-commercial republication encouraged - Please include this sig *
      * Please Cc: •••@••.••• directly on forwards & replies *